Belite Bio(BLTE) - 2024 Q3 - Earnings Call Presentation

| --- | --- | --- | --- | |-------|----------------------------------------------------------------------------|-------|-------| | | | | | | | | | | | | Early Intervention with | | | | | Mission for Vision Nasdaq: BLTE an Oral Treatment for Macular Degeneration | | | Forward-Looking Statements and Legal Disclaimer This presentation (including any oral briefing and any question-and-answer in connection with it) is not intended to, and does not constitute, represent or form part of any offer, invitation or so ...